(SSNC) SS&C Technologies Holdings - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US78467J1007
Stock: Portfolio, Trading, Healthcare, Reconciliation, Consulting
Total Rating 38
Risk 76
Buy Signal 0.22
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.22% |
| Yield on Cost 5y | 1.66% |
| Yield CAGR 5y | 11.21% |
| Payout Consistency | 100.0% |
| Payout Ratio | 21.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 43.1% |
| Relative Tail Risk | -4.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.47 |
| Alpha | -19.37 |
| Character TTM | |
|---|---|
| Beta | 0.842 |
| Beta Downside | 0.946 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.06% |
| CAGR/Max DD | 0.39 |
Description: SSNC SS&C Technologies Holdings December 19, 2025
SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) delivers a vertically integrated suite of software and software-enabled services to the financial services and healthcare sectors, covering the full workflow from front-office trading and modeling through middle-office portfolio management to back-office accounting, compliance, and clearing, as well as claims adjudication and care-management tools for health providers.
In FY 2023 the company reported revenue of roughly $6.5 billion, a year-over-year increase of about 8%, driven by strong growth in its SaaS-based investment-management platform (ARR now exceeds $5.5 billion). The client base exceeds 8,000 institutions, and operating margins have improved to ~14% as the firm scales its managed services and data-solution offerings. A key sector driver is the accelerating migration of asset managers to cloud-native, low-latency trading and compliance suites, which is bolstered by regulatory pressure for real-time reporting and by fee-compression trends that favor cost-efficient technology partners.
For a deeper quantitative view, the ValueRay platform offers granular financial metrics and peer comparisons worth exploring.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 796.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 2.43 > 1.0 |
| NWC/Revenue: 6.00% < 20% (prev 8.64%; Δ -2.64% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.56b > Net Income 796.9m |
| Net Debt (-223.9m) to EBITDA (1.96b): -0.11 < 3 |
| Current Ratio: 1.07 > 1.5 & < 3 |
| Outstanding Shares: last quarter (251.5m) vs 12m ago -0.91% < -2% |
| Gross Margin: 48.17% > 18% (prev 0.49%; Δ 4769 % > 0.5%) |
| Asset Turnover: 31.55% > 50% (prev 30.89%; Δ 0.67% > 0%) |
| Interest Coverage Ratio: 2.51 > 6 (EBITDA TTM 1.96b / Interest Expense TTM 426.3m) |
Altman Z'' 1.64
| A: 0.02 (Total Current Assets 5.49b - Total Current Liabilities 5.11b) / Total Assets 20.71b |
| B: 0.20 (Retained Earnings 4.05b / Total Assets 20.71b) |
| C: 0.05 (EBIT TTM 1.07b / Avg Total Assets 19.88b) |
| D: 0.50 (Book Value of Equity 6.89b / Total Liabilities 13.77b) |
| Altman-Z'' Score: 1.64 = BB |
Beneish M -3.10
| DSRI: 0.90 (Receivables 3.93b/4.11b, Revenue 6.27b/5.88b) |
| GMI: 1.01 (GM 48.17% / 48.68%) |
| AQI: 0.99 (AQ_t 0.71 / AQ_t-1 0.72) |
| SGI: 1.07 (Revenue 6.27b / 5.88b) |
| TATA: -0.04 (NI 796.9m - CFO 1.56b) / TA 20.71b) |
| Beneish M-Score: -3.10 (Cap -4..+1) = AA |
What is the price of SSNC shares?
As of February 10, 2026, the stock is trading at USD 76.43 with a total of 2,519,367 shares traded.
Over the past week, the price has changed by -7.03%, over one month by -12.19%, over three months by -9.68% and over the past year by -11.37%.
Over the past week, the price has changed by -7.03%, over one month by -12.19%, over three months by -9.68% and over the past year by -11.37%.
Is SSNC a buy, sell or hold?
SS&C Technologies Holdings has received a consensus analysts rating of 4.33.
Therefore, it is recommended to buy SSNC.
- StrongBuy: 6
- Buy: 4
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SSNC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 99.7 | 30.4% |
| Analysts Target Price | 99.7 | 30.4% |
| ValueRay Target Price | 79.3 | 3.7% |
SSNC Fundamental Data Overview February 08, 2026
P/E Trailing = 24.5683
P/E Forward = 11.3895
P/S = 3.074
P/B = 2.6565
P/EG = 0.8379
Revenue TTM = 6.27b USD
EBIT TTM = 1.07b USD
EBITDA TTM = 1.96b USD
Long Term Debt = 6.57b USD (from longTermDebt, two quarters ago)
Short Term Debt = 25.0m USD (from shortTermDebt, last quarter)
Debt = 238.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -223.9m USD (from netDebt column, last quarter)
Enterprise Value = 18.68b USD (18.90b + Debt 238.2m - CCE 462.1m)
Interest Coverage Ratio = 2.51 (Ebit TTM 1.07b / Interest Expense TTM 426.3m)
EV/FCF = 11.51x (Enterprise Value 18.68b / FCF TTM 1.62b)
FCF Yield = 8.69% (FCF TTM 1.62b / Enterprise Value 18.68b)
FCF Margin = 25.88% (FCF TTM 1.62b / Revenue TTM 6.27b)
Net Margin = 12.71% (Net Income TTM 796.9m / Revenue TTM 6.27b)
Gross Margin = 48.17% ((Revenue TTM 6.27b - Cost of Revenue TTM 3.25b) / Revenue TTM)
Gross Margin QoQ = 47.77% (prev 47.69%)
Tobins Q-Ratio = 0.90 (Enterprise Value 18.68b / Total Assets 20.71b)
Interest Expense / Debt = 46.77% (Interest Expense 111.4m / Debt 238.2m)
Taxrate = 11.86% (26.1m / 220.1m)
NOPAT = 942.8m (EBIT 1.07b * (1 - 11.86%))
Current Ratio = 1.07 (Total Current Assets 5.49b / Total Current Liabilities 5.11b)
Debt / Equity = 0.03 (Debt 238.2m / totalStockholderEquity, last quarter 6.89b)
Debt / EBITDA = -0.11 (Net Debt -223.9m / EBITDA 1.96b)
Debt / FCF = -0.14 (Net Debt -223.9m / FCF TTM 1.62b)
Total Stockholder Equity = 6.88b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.01% (Net Income 796.9m / Total Assets 20.71b)
RoE = 11.57% (Net Income TTM 796.9m / Total Stockholder Equity 6.88b)
RoCE = 7.95% (EBIT 1.07b / Capital Employed (Equity 6.88b + L.T.Debt 6.57b))
RoIC = 6.91% (NOPAT 942.8m / Invested Capital 13.64b)
WACC = 9.42% (E(18.90b)/V(19.14b) * Re(9.02%) + D(238.2m)/V(19.14b) * Rd(46.77%) * (1-Tc(0.12)))
Discount Rate = 9.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.12%
[DCF Debug] Terminal Value 72.89% ; FCFF base≈1.39b ; Y1≈1.37b ; Y5≈1.43b
Fair Price DCF = 81.52 (EV 19.67b - Net Debt -223.9m = Equity 19.89b / Shares 244.0m; r=9.42% [WACC]; 5y FCF grow -1.72% → 2.90% )
EPS Correlation: 15.67 | EPS CAGR: 8.37% | SUE: 0.95 | # QB: 2
Revenue Correlation: 97.94 | Revenue CAGR: 6.73% | SUE: 2.67 | # QB: 3
EPS next Quarter (2026-03-31): EPS=1.65 | Chg30d=+0.014 | Revisions Net=-2 | Analysts=7
EPS current Year (2026-12-31): EPS=6.83 | Chg30d=+0.196 | Revisions Net=-3 | Growth EPS=+11.2% | Growth Revenue=+6.5%
EPS next Year (2027-12-31): EPS=7.38 | Chg30d=+0.195 | Revisions Net=-2 | Growth EPS=+8.2% | Growth Revenue=+4.8%
P/E Forward = 11.3895
P/S = 3.074
P/B = 2.6565
P/EG = 0.8379
Revenue TTM = 6.27b USD
EBIT TTM = 1.07b USD
EBITDA TTM = 1.96b USD
Long Term Debt = 6.57b USD (from longTermDebt, two quarters ago)
Short Term Debt = 25.0m USD (from shortTermDebt, last quarter)
Debt = 238.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -223.9m USD (from netDebt column, last quarter)
Enterprise Value = 18.68b USD (18.90b + Debt 238.2m - CCE 462.1m)
Interest Coverage Ratio = 2.51 (Ebit TTM 1.07b / Interest Expense TTM 426.3m)
EV/FCF = 11.51x (Enterprise Value 18.68b / FCF TTM 1.62b)
FCF Yield = 8.69% (FCF TTM 1.62b / Enterprise Value 18.68b)
FCF Margin = 25.88% (FCF TTM 1.62b / Revenue TTM 6.27b)
Net Margin = 12.71% (Net Income TTM 796.9m / Revenue TTM 6.27b)
Gross Margin = 48.17% ((Revenue TTM 6.27b - Cost of Revenue TTM 3.25b) / Revenue TTM)
Gross Margin QoQ = 47.77% (prev 47.69%)
Tobins Q-Ratio = 0.90 (Enterprise Value 18.68b / Total Assets 20.71b)
Interest Expense / Debt = 46.77% (Interest Expense 111.4m / Debt 238.2m)
Taxrate = 11.86% (26.1m / 220.1m)
NOPAT = 942.8m (EBIT 1.07b * (1 - 11.86%))
Current Ratio = 1.07 (Total Current Assets 5.49b / Total Current Liabilities 5.11b)
Debt / Equity = 0.03 (Debt 238.2m / totalStockholderEquity, last quarter 6.89b)
Debt / EBITDA = -0.11 (Net Debt -223.9m / EBITDA 1.96b)
Debt / FCF = -0.14 (Net Debt -223.9m / FCF TTM 1.62b)
Total Stockholder Equity = 6.88b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.01% (Net Income 796.9m / Total Assets 20.71b)
RoE = 11.57% (Net Income TTM 796.9m / Total Stockholder Equity 6.88b)
RoCE = 7.95% (EBIT 1.07b / Capital Employed (Equity 6.88b + L.T.Debt 6.57b))
RoIC = 6.91% (NOPAT 942.8m / Invested Capital 13.64b)
WACC = 9.42% (E(18.90b)/V(19.14b) * Re(9.02%) + D(238.2m)/V(19.14b) * Rd(46.77%) * (1-Tc(0.12)))
Discount Rate = 9.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.12%
[DCF Debug] Terminal Value 72.89% ; FCFF base≈1.39b ; Y1≈1.37b ; Y5≈1.43b
Fair Price DCF = 81.52 (EV 19.67b - Net Debt -223.9m = Equity 19.89b / Shares 244.0m; r=9.42% [WACC]; 5y FCF grow -1.72% → 2.90% )
EPS Correlation: 15.67 | EPS CAGR: 8.37% | SUE: 0.95 | # QB: 2
Revenue Correlation: 97.94 | Revenue CAGR: 6.73% | SUE: 2.67 | # QB: 3
EPS next Quarter (2026-03-31): EPS=1.65 | Chg30d=+0.014 | Revisions Net=-2 | Analysts=7
EPS current Year (2026-12-31): EPS=6.83 | Chg30d=+0.196 | Revisions Net=-3 | Growth EPS=+11.2% | Growth Revenue=+6.5%
EPS next Year (2027-12-31): EPS=7.38 | Chg30d=+0.195 | Revisions Net=-2 | Growth EPS=+8.2% | Growth Revenue=+4.8%